See the DrugPatentWatch profile for cosentyx

The MMR (Measles, Mumps, and Rubella) vaccine is a live attenuated vaccine, while Cosentyx (secukinumab) is a monoclonal antibody used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].

There is no evidence or known mechanism suggesting that the MMR vaccine could cause side effects when administered with Cosentyx. The MMR vaccine's side effects are typically mild and include fever, rash, and soreness at the injection site [2]. Cosentyx's common side effects include upper respiratory infections, headache, and injection site reactions [3].

However, it is essential to inform healthcare providers about all medications, vaccines, and supplements being taken, as interactions and side effects are not always predictable [1]. If you have concerns or questions about potential interactions between the MMR vaccine and Cosentyx, consult your healthcare provider or pharmacist.

Sources:

1. [DrugPatentWatch.com](https://drugpatentwatch.com/drugs/cosentyx).
2. Centers for Disease Control and Prevention. MMR (Measles, Mumps, and Rubella) Vaccine. <https://www.cdc.gov/vaccines/vpd/mmr/public/index.html>.
3. Novartis. Cosentyx (secukinumab) Prescribing Information. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.